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Abstract
Background. Artiﬁcial neural networks (ANN) repre-
sent a promising alternative to classical statistical and
mathematical methods to solve multidimensional non-
linear problems. The aim of the study was to compare
the performance of ANN in predicting the dialysis
quality (Kt/V), the follow-up dietary protein intake
and the risk of intradialytic hypotension in haemo-
dialysis patients with that predicted by experienced
nephrologists.
Methods. A combined retrospective and prospective
observational study was performed in two Swiss
dialysis units (80 chronic haemodialysis patients, 480
monthly clinical observations and biochemical test
results). Using mathematical models based on linear
and logistic regressions as background, ANN were
built and then prospectively compared with the ability
of six experienced nephrologists to predict the Kt/V
and the follow-up protein catabolic rate (PCR) and to
detect a Kt/V <1.30, a follow-up PCR <1.00 g/kg/day
and the occurrence of hypotension.
Results. ANN compared with nephrologists gave a
more accurate correlation between estimated and
calculated Kt/V and follow-up PCR (P<0.001). The
same superiority of ANN was also seen in the ability to
detect a Kt/V <1.30, a follow-up PCR <1.00 g/kg/day
and the occurrence of hypotension expressed as a
percentage of correct answers, sensitivity, speciﬁcity
and predictivity.
Conclusions. The use of ANN signiﬁcantly improves
the ability of experienced nephrologists to estimate
the Kt/V and the follow-up PCR and to detect a
Kt/V <1.30, a follow-up PCR <1.00 g/kg/day and the
occurrence of intradialytic hypotension.
Keywords: artiﬁcial neural networks; haemodialysis;
hypotension risk; Kt/V; prediction; protein catabolic
rate
Introduction
Nephrologists treating haemodialysis patients are
faced with a large amount of clinical and biochemical
historical data that have to be used to make clinical
decisions. In this task, the physicians’ experience
assigning different weights to the known parameters
continuously improves, allowing the elaboration of
diagnostic and therapeutic strategies. Statistical
models as multivariate linear or logistic regressions
might ameliorate the outcome of the prediction based
on intuition, but even these statistical procedures
present limits due to the non-linearity of the multi-
dimensional functions studied. In many ﬁelds of
clinical medicine, artiﬁcial neural networks (ANN)
have been used successfully to solve complex and
chaotic problems without the need of mathematical
models and a precise understanding of the mechanisms
involved [1–3]. Pharmacodynamic analysis [4–6]
(cyclosporin dosage adjustment [7], heparin pharma-
cokinetics during haemodialysis [8]), time-course and
diagnosis of chronic nephropathies (IgA nephropathy
[9], glomerular vs tubular renal disease [10]), allograft
tolerance and function (chronic and acute allograft
rejection [11–14]), diagnosis of renal transplant rejec-
tion [15], prediction of cytomegalovirus disease after
renal transplantation [16], stratiﬁcation of cardiac
risk in renal transplantation [17] and haemodialysis
efﬁciency evaluation (urea kinetic modelling [18,19])
are only a few examples of the artiﬁcial intelligence
opportunities.
We decided to investigate the ability of an artiﬁcial
intelligence software based on ANN to predict the
Kt/V, the follow-up protein catabolic rate (PCR) and
the risk of hypotension during a dialysis session in a
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group of chronic haemodialysis patients. The predic-
tions obtained with ANN, built keeping in mind the
results of mathematical models based on linear or
logistic regressions, were then compared with those
obtained after submission of the same data to
experienced nephrologists in charge of these patients.
The aim of the study was to verify whether ANN are
useful tools in daily clinical practice to predict the
dialysis quality, the follow-up dietary protein intake
and the risk of hypotension.
Subjects and methods
A ﬁrst random sample of chronic haemodialysis patients was
selected from two independent dialysis units in south
Switzerland in order to collect, retrospectively, the monthly
clinical, biochemical and anthropometric parameters neces-
sary to calculate the Kt/V, the theoretical Kt/V, the
normalized PCR and to identify the haemodialysis sessions
with symptomatic hypotension episodes. In order to estimate
the changes of the protein intake, a supplementary column
listing the PCR value of 1 month after the basis PCR (follow-
up PCR) was added to the data table. With the intention to
identify, on the basis of a classical statistical method, the data
inﬂuencing the chosen dependent variables (Kt/V, follow-up
PCR and hypotension episodes) and to build a mathematical
estimation model, a linear regression for continuous data
(Kt/V and follow-up PCR) and a logistic regression for
dichotomous data (hypotension episodes) was performed.
Furthermore, with the aim of building non-linear continuous
functions exploring and expressing the interdependency
between the collected data and the cited dependent variables,
a series of ANN were trained until they were successfully
tested. Finally, we selected, in a prospective way, a second
chronic haemodialysis patient group from the same two
independent dialysis centres in order to test the selected ANN
and to compare their performance with the prediction of six
experienced nephrologists of the same geographical region.
Patients and laboratory tests
We studied two random samples of 60 (control group; 420
biochemical and clinical monthly data) and 20 (experimental
group; 60 biochemical and clinical monthly data) chronic
haemodialysis patients (older than 17 years) treated for >6
months and without intercurrent illnesses at the moment of
the enrolment.
The haemodialysis sessions were performed using a 4008
H bicarbonate-bag machine and a high-ﬂux polysulfone
membrane, both from Fresenius Medical Care (Stams,
Switzerland).
Calculation of Kt/V, theoretical Kt/V and PCR
The Kt/V was calculated with a second generation single-
pool Daugirdas formula [20]:
Kt=V ¼ lnðR 0:03Þ þ ½ð4 3:5RÞ  ðUF=WÞ
where R¼ post-dialysis blood urea nitrogen (BUN)/pre-
dialysis BUN, UF¼ net ultraﬁltration and W¼weight.
The theoretical Kt/V was calculated with the following
formula [21]:
Theoretical Kt=V
¼ Qb exp½ðKoA=QbÞð1Qb=QdÞ  1
exp½ðKoA=QbÞð1Qb=QdÞ  ðQb=QdÞ dT0:82=W
where Qb¼ blood ﬂow, KoA¼ urea mass transfer area
coefﬁcient, Qd¼ dialysate ﬂow, dT¼ dialysis duration and
W¼weight. The normalized PCR was calculated with the
Jindal and Goldstein formula [22]:
PCR ¼ 0:22þ ½0:036 ðFollow-up BUN
 Post-dialysis BUNÞ  24=ID interval
where follow-up BUN¼BUN at the beginning of the second
dialysis session of the week, post-dialysis BUN¼BUN at
the end of the ﬁrst dialysis session of the week and ID
interval¼ time interval between the two dialyses.
The results of the calculated monthly dialysis quality and
nutritional parameters were for the control and experimental
groups, respectively: Kt/V 1.39±0.31 vs 1.38±0.25, theore-
tical Kt/V 1.41±0.39 vs 1.23±0.26 and PCR 1.16±0.26 vs
1.07±0.22 g/kg/day.
Deﬁnition of symptomatic hypotension during
the dialysis treatment
Hypotension episodes were deﬁned as symptomatic falls of
the systolic blood pressure below 90mmHg or sudden and
symptomatic falls of the systolic blood pressure of >30%
of the previous measured values requiring isotonic saline
infusion.
Artiﬁcial neural networks
ANN are accepted mathematical methods to translate
complex multivariate non-linear relationships into continu-
ous functions. According to Kolmogorov’s theorem, paying
attention to network structure, any arbitrary continuous
function expressing the dependent variable on the basis of the
input data may be built. ANN were created, trained (back-
propagation algorithm) and tested using the BrainMaker
Professional software (California Scientiﬁc Software 3.75).
On the basis of a constant learning rate, the training
tolerance and the percentage of good facts to stop training
for each model were at ﬁrst set at 15% and 95%, respectively.
According to the recommendations of the software producer
to optimize the performance of the network, the number of
hidden layers was limited to one. This was built with the
number of neurons equal to the number of input nodes if
10 or with 10 neurons for a number of input nodes
<10 (default settings). Furthermore, to estimate the suitable
minimum and maximum numbers of hidden neurons, the
following two formulae were used:
Minimum number of hidden neurons
¼ ðNumber facts=10Þ  Input nodesOutput nodes
Maximum number of hidden neurons
¼ ðNumber of facts=2Þ  Input nodesOutput nodes
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(guideline 2 of the BrainMaker Professional reference
manual). The number of connections was then calculated
as follows (Figure 1):
½ðInput nodesþ 1Þ Hidden neurons
þ ½ðHidden neuronsþ 1Þ Output nodes
The ‘1’ added optionally to both the input and the hidden
layers represents a threshold neuron; an extra neuron that
always ﬁres at full strength allows the neurons in the next
layer to have a non-zero output even if all inputs are zeros.
A sigmoid transfer function was chosen for each neuron.
An ANN was then designed and trained with the training
tolerance and the percentage of good facts to stop training
set, respectively, at 15% and 95% for the ﬁrst attempt to
obtain a successfully testable ANN, modifying then the
tolerance stepwise from alternately plus or minus 0.5% until
ﬁve ANN for each of the three dependent variables (Kt/V,
follow-up PCR and hypotension episodes) were successfully
tested (>85% of correct answers with a tolerance of 20%).
As input nodes, the variables known or supposed to inﬂu-
ence the value of the desired prediction (according to
literature data, intuition and results of the linear and logis-
tic regressions) have been used: nutritional (pre-dialysis
serum phosphate, serum albumin, pre-dialysis creatinine,
pre-dialysis BUN, pre-dialysis potassium and pre-dialysis
ionized calcium), anthropometric (sex, age and body mass
index), biological (haematocrit) and dialysis quality (post-
dialysis weight, net ultraﬁltration, Qb dialysis duration and
dialyser surface area) parameters to predict Kt/V (15 input
variables, 15 hidden neurons and 255 connections), nutri-
tional (pre-dialysis serum phosphate, serum albumin, net
ultraﬁltration, pre-dialysis BUN and PCR) and dialysis
quality (Kt/V) parameters to predict follow-up PCR (six
input variables, 10 hidden neurons and 81 connections) and
nutritional (serum albumin, body mass index, pre-dialysis
creatinine, pre-dialysis BUN, pre-dialysis ionized calcium
and pre-dialysis pH), anthropometric (sex, age and post-
dialysis weight), biological (haematocrit) and dialysis (dial-
ysis duration, Qb, net ultraﬁltration, dialysate sodium and
calcium concentrations and dialyser surface area) parameters
to predict the occurrence of hypotension (16 input variables,
16 hidden neurons and 289 connections). The study was
designed according to the prescriptions of Cross et al. [3].
Statistical and data analysis
Statistical and data analysis was performed using two
different statistical software packages (Systat 7.0 and SPSS
11.0; SPSS Inc.). Systat was used to perform the multivariate
Fig. 1. Schematic representation of the ANN used to predict the occurrence of hypotension episodes: 16þ 1a input variables, 16þ 1a hidden
neurons and 289 connections (athreshold node and neuron added to avoid a zero output in the following layer).
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logistic regression involving the hypotension substudy,
whereas SPSS was used to elaborate the multivariate linear
regression of the Kt/V and follow-up PCR substudies. Non-
parametric kernel density estimators were used to show the
distribution of the relative error generated from the estima-
tion of the Kt/V and follow-up PCR. The differences
between kernel curves were judged with a repeated-measure
analysis of variance (ANOVA) and a post-hoc Bonferroni
test. In all cases a P-value of 0.05 was considered
statistically signiﬁcant. Accuracy is expressed by the com-
bined root mean square error calculated as the square root of
[(mean difference in estimate – observed)2þ (SD of the
difference)2]. Agreement between the predictions and the
basis data is expressed by ‘limits of agreement’, ‘95%
conﬁdence interval for the bias’ and ‘95% conﬁdence interval
for the lower and upper limits of agreement’, according to
Bland and Altman [23]. For Kt/V and follow-up PCR, results
were expressed using a cut-off of, respectively, 1.30 and
1.00 g/kg/day to deﬁne correct answers and consequently
sensitivity, speciﬁcity and predictivity (¼ positive predictive
value) of the ANN or nephrologists estimations. The
differences between these data were judged with a two
samples Student’s t-test. Values are presented as means±SD.
Comparison with experienced nephrologists
Six nephrologists from three different Swiss dialysis centres
were shown the monthly clinical, biochemical and anthro-
pometric data of the experimental group and they were asked
to predict the Kt/V, the follow-up PCR and the occurrence of
hypotension. The distribution of the error in the prediction
(for Kt/V and follow-up PCR), the amount of correct
answers, the sensitivity, the speciﬁcity and the predictivity
were than compared with the results obtained with the
selected ANN.
Results
The characteristics of the studied populations, the
haemodialysis prescriptions and the results of the
monthly biochemical parameters in the experimental
and control groups are listed in Table 1. Table 2 shows
the results of the logistic regression for the estima-
tion of occurrence of hypotension during dialysis
(P<0.001) and of the linear regressions for the
estimation of the Kt/V (P<0.001) and the follow-up
PCR (P<0.001). The model for the estimation of
occurrence of hypotension gives a signiﬁcant correla-
tion only for age, net ultraﬁltration, serum phosphate
and dialysate sodium; that for the estimation of Kt/V
demonstrates a signiﬁcant correlation only for body
mass index, net ultraﬁltration and serum pH, BUN
and creatinine and, ﬁnally, only serum phosphate
and BUN, basis PCR and dialysate calcium show a
signiﬁcant correlation for follow-up PCR.
Figure 2 depicts graphically the distribution of the
absolute error for the estimation of Kt/V predicted
from ANN, nephrologists and obtained with the
Table 1. Characteristics of the studied populations, haemodialysis prescriptions and results of the monthly biochemical parameters in the
experimental and control groups
Characteristic Control group Experimental group
Age (years) 70±13 69±13
Dry weight (kg) 68±11 69±8
Body mass index (kg/m2) 25±3 25±3
Net ultraﬁltration (ml) 1490±1220 1400±1040
Male/female ratio 1 1
Haemodialysis duration (h) 3.28±0.47 3.06±0.28
Dialyser effective surface area (m2) 1.8±0.3 1.8±0.3
KoA urea (ml/min) 1242±97 1239±95
Effective blood ﬂow (ml/min) 307±71 302±62
Dialysis ﬂuid temperature (C) 36.5±0 36.5±0
Dialysis ﬂuid ﬂow rate (ml/min) 600±0 600±0
Dialysis ﬂuid sodium (mmol/l) 139±1 139±1
Dialysis ﬂuid potassium (mmol/l) 2.4±0.9 2.5±0.7
Dialysis ﬂuid calcium (mmol/l) 1.42±0.19 1.47±0.18
Dialysis ﬂuid bicarbonate (mmol/l) 31±1 31±1
Dialysis ﬂuid magnesium (mmol/l) 0.5±0 0.5±0
Dialysis ﬂuid acetate (mmol/l) 3.0±0 3.0±0
Dialysis ﬂuid glucose (g/l) 1.0±0 1.0±0
Pre-dialysis creatinine (mmol/l) 698±213 693±219
Post-dialysis creatinine (mmol/l) 273±83 273±80
Pre-dialysis BUN (mmol/l) 24.9±6.6 22.5±5.7
Post-dialysis BUN (mmol/l) 7.7±3.0 6.9±2.4
Pre-dialysis potassium (mmol/l) 5.3±0.8 5.1±0.6
Post-dialysis potassium (mmol/l) 3.8±0.3 3.8±0.4
Pre-dialysis phosphate (mmol/l) 1.69±0.52 1.58±0.64
Pre-dialysis ionized calcium (mmol/l) 1.23±0.13 1.15±0.10
Pre-dialysis pH 7.38±0.04 7.37±0.05
Pre-dialysis haematocrit (%) 33.7±4.1 34.8±4.0
Pre-dialysis albumin (g/l) 36.9±3.5 35.5±3.7
Values are means±SD.
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Brenner and Drukker formula. The ANOVA of the
absolute value of the error for the three predictions
reaches a signiﬁcant level, which is compatible with the
curves behaviour. The differences between the ANN
curve and the other two is signiﬁcant according to a
post-hoc Bonferroni test. Similarly, Figure 3 shows the
same curves for the estimation of follow-up PCR
predicted from ANN and nephrologists. The ANOVA
Table 2. Results of the logistic regression for the estimation of occurrence of hypotension during dialysis and of the linear regressions for
the estimation of Kt/V and follow-up PCR
Dependent variable Hypotension Kt/V Follow-up PCR
Statistical method Logistic regression Linear regression Linear regression





Sex 2.48 0.100 0.03 0.157 0.45 0.452
Age 1.06 0.002 0.01 0.795 0.08 0.112
Body mass index 1.62 0.386 0.34 0.010 0.50 0.089
Dry weight 0.81 0.432 0.28 0.028 0.62 0.072
Ultraﬁltration 0.85 0.000 0.16 0.000 0.00 0.978
Dialysis duration 1.61 0.830 0.05 0.429 0.04 0.807
Blood ﬂow 1.00 0.965 0.20 0.388 0.08 0.900
Phosphatea 2.46 0.012 0.01 0.605 0.09 0.031
Potassiuma 0.74 0.367 0.02 0.325 0.05 0.407
Ionized calciuma 12.8 0.147 0.02 0.308 0.03 0.460
pHa 0.29 0.748 0.05 0.002 0.02 0.653
Creatininea 1.00 0.506 0.17 0.000 0.25 0.065
BUNa 0.99 0.955 0.66 0.000 0.41 0.015
Haematocrit 1.06 0.244 0.03 0.070 0.05 0.220
Albumina 0.98 0.764 0.03 0.108 0.05 0.291
Kt/V 11.2 0.196 N/A N/A 0.09 0.523
PCR 0.53 0.695 N/A N/A 0.66 0.000
Potassiumb 1.62 0.153 0.00 0.968 0.05 0.403
Sodiumb 1.38 0.010 0.01 0.500 0.05 0.259
Calciumb 0.57 0.521 0.01 0.650 0.08 0.041
Dialyser area 0.23 0.191 0.03 0.122 0.06 0.253
aIn serum at the beginning of the dialysis session; bin dialysate. N/A, not available for estimation.
Fig. 3. Non-parametric kernel density estimator (analogous to a
continuous histogram that shows where the data are most
concentrated in the sample) showing the distribution of the absolute
error for the estimation of follow-up PCR. Dashed line, ANN; solid
line, nephrologists. P-values for the differences between the curves
have been superimposed on the graph.
Fig. 2. Non-parametric kernel density estimator (analogous to a
continuous histogram that shows where the data are most
concentrated in the sample) showing the distribution of the absolute
error for the estimation of Kt/V. Dashed line, ANN; solid line,
nephrologists; dashed and dotted line, theoretical Kt/V obtained
with the Brenner and Drukker formula. P-values for the differences
between the curves have been superimposed on the graph.
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of the absolute value of the error for the two
predictions also reaches a signiﬁcant level for these
distributions.
According to Bland and Altman, agreements
between the predictions and the basis data expressed
by ‘limits of agreement’, ‘95% conﬁdence interval for
the bias’ and ‘95% conﬁdence interval for the lower
and upper limits of agreement’ are given in Table 3.
These results are concordant with the previous
statistical analysis and conﬁrm the overall reduction
in the magnitude of the error by the use of ANN.
Histograms showing the percentage of correct
answers, sensitivity, speciﬁcity and predictivity in the
estimation of the occurrence of hypotension, of the
Kt/V (lower or higher than 1.30) and of follow-up
PCR (lower or higher than 1.00 g/kg/day) for the
ANN and the nephrologists are presented in Figure 4,
whereas the absolute numbers of correct answers, true
and false positive and false negative in the same
estimations are listed in Table 4.
Discussion
In the evaluation of chronic haemodialysis patients,
biochemical data determined at monthly intervals, as
well as clinical parameters registered at each dialysis
session, hide important information that could be very
useful for the management of the patients and for the
continuing education of the nephrologist himself. Our
data show that the use of ANN enables to achieve a
better prediction of Kt/V, follow-up PCR and occur-
rence of intradialytic hypotension than the intuitive
prediction of experienced nephrologists.
Mathematical models based on usual statistics are
often disappointing when used to analyse multidimen-
sional non-linear data. In fact, logistic regression
applied to the risk of hypotension (dichotomous
data) and linear regressions used to estimate Kt/V
and follow-up PCR (continuous variables), on the one
hand, did not permit building a model that could be
used in the daily clinical practice and, on the other,
Table 3. Accuracy expressed by the combined root mean square error, agreement expressed by the ‘limits of agreement’, the ‘95%
conﬁdence interval for the bias’ (95% bias) and the ‘95% conﬁdence interval for the lower (95% lower) and upper (95% upper) limits of
agreement’ in the estimation of Kt/V and follow-up PCR. P-values are speciﬁed only if differences are signifcant
Estimation of Kt/V Estimation of follow-up PCR
ANN Nephrologists Theoretical Kt/V ANN Nephrologists
Accuracy 0.17±0.01 0.30±0.04 0.37 0.15±0.01 0.21±0.04
P<0.001 P<0.01
LA 0.37±0.03 0.65±0.10 0.03 0.26±0.06 0.32±0.09
P<0.001
0.30±0.04 0.38±0.15 0.06 0.32±0.02 0.45±0.09
P<0.001
95% Bias –0.07±0.02 –0.18±0.08 –0.25 0.00±0.03 0.03±0.02
P<0.01 P<0.05
–0.01±0.02 –0.09±0.09 –0.14 0.06±0.03 0.10±0.02
P<0.05 P<0.01
95% Lower –0.42±0.03 –0.73±0.11 –0.91 –0.31±0.06 –0.38±0.10
P<0.001
–0.32±0.02 –0.57±0.09 –0.72 –0.22±0.05 –0.26±0.08
P<0.001
95% Upper 0.25±0.04 0.31±0.14 0.34 0.28±0.02 0.40±0.08
P<0.001
0.35±0.05 0.46±0.16 0.53 0.37±0.02 0.51±0.11
P<0.001
Values are means±SD. LA, limits of agreement.
Table 4. Ability to detect a Kt/V <1.30, a PCR <1.00 g/kg/day and hypotension episodes expressed as correct answers, true and false
positive and false negative (n¼ 60). P-values are speciﬁed only if differences are signiﬁcant
Kt/V<1.30 (n¼ 19) PCR<1.00 g/kg/day (n¼ 24) Hypotension episodes (n¼ 13)
ANN NEPH ANN NEPH ANN NEPH
Correct answers 48.7±0.5 34.0±3.8 49.8±1.3 41.6±3.4 46.7±2.3 45.0±2.6
P<0.001 P<0.001
True positive 16.0±0.0 14.3±3.9 17.4±0.9 8.8±1.9 9.7±1.0 2.5±2.4
P<0.001 P<0.01
False positive 8.2±0.5 21.3±5.0 3.6±0.6 3.2±2.4 10.0±3.2 4.5±2.1
P<0.01 P<0.05
False negative 3.0±3.0 4.7±3.9 6.6±0.9 15.2±1.9 3.2±1.0 10.5±2.4
P<0.001 P<0.01
Values are means±SD. NEPH, nephrologists.
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sometimes gave disconcerting results. For instance, in
the linear regression using Kt/V as the dependent
variable, body mass index, dry weight, ultraﬁltration
and pre-dialysis BUN, creatinine, pH and haematocrit
contrary to blood ﬂow, dialyser area and dialysis
duration surprisingly gave no signiﬁcant correlations.
Keeping in mind that for the calculation of Kt/V we
used a single-pool model that gave an estimation of
the true value based only on BUN, dry weight and
ultraﬁltration and that the variability in the distribu-
tion of the data for blood ﬂow, dialyser area and
dialysis duration in the studied population was low, the
beta-coefﬁcients and the P-values of the linear regres-
sion are not as strange as they appear at ﬁrst sight.
Furthermore, linear regressions, as expressed by their
name, are not able to show positive correlations based
on non-linear functions, such as logarithmic, exponen-
tial or polynomial.
Data multidimensionality and non-linearity are the
typical application ﬁelds for artiﬁcial intelligence and,
in particular, for ANN. These programs have been
successfully utilized in various medical specialties and
the number of published studies demonstrates that the
subject is in continuous rapid expansion [4–19].
Our data, in the absence of previous comparable
studies, show that:
(i) The information contained in the historical
biochemical results and clinical parameters of
the patients might signiﬁcantly improve the
ability of nephrologists to predict the occur-
rence of intradialytic hypotension episodes.
This means that our intuition, even if supported
by long experience and the classical statistical
methods, misses out on an important part of the
usually available information.
(ii) The useful experience of the nephrologists
enables a more accurate prediction of Kt/V
than the algorithm proposed by Brenner and
Drukker [22].
(iii) Nevertheless, in the estimation of Kt/V, arti-
ﬁcial intelligence can further improve the
prediction.
(iv) Even in the prediction of follow-up PCR, which
in day to day experience might resemble an
unsolvable task, ANN demonstrate their posi-
tive performance and potential usefulness.
In conclusion, our data show that ANN can give a
signiﬁcant contribution and be helpful tools in clinical
practice for the nephrologist treating chronic haemo-
dialysis patients. The correct appreciation of the
intradialytic hypotension risk and of the trend in
the evolution of the nutritional state are two capi-
tal challenges that could be solved by an ANN
approach, thus permitting the application of prophy-
lactic measures.
Future studies will show in which way the ANN
performance could be further improved by increasing
the extension of the retrospective data-pool and/or by
the application of the method to the clinical course of a
single patient.
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